Cargando…

Combination of Anlotinib and Celecoxib for the Treatment of Abdominal Desmoid Tumor: A Case Report and Literature Review

Desmoid tumor is a rare disease, which is histologically characterized by local invasion, monoclonality, and fibroblast proliferation; and clinically characterized by a variable and often unpredictable course. The treatment of desmoid tumor is mainly surgical resection, but the recurrence rate is hi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jianzheng, Li, Hongle, Wang, Hui, Li, Qingli, Bai, Xuanye, Lv, Huifang, Nie, Caiyun, Chen, Beibei, Xu, Weifeng, Tu, Shuiping, Chen, Xiaobing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792388/
https://www.ncbi.nlm.nih.gov/pubmed/35096630
http://dx.doi.org/10.3389/fonc.2021.830672
_version_ 1784640350105632768
author Wang, Jianzheng
Li, Hongle
Wang, Hui
Li, Qingli
Bai, Xuanye
Lv, Huifang
Nie, Caiyun
Chen, Beibei
Xu, Weifeng
Tu, Shuiping
Chen, Xiaobing
author_facet Wang, Jianzheng
Li, Hongle
Wang, Hui
Li, Qingli
Bai, Xuanye
Lv, Huifang
Nie, Caiyun
Chen, Beibei
Xu, Weifeng
Tu, Shuiping
Chen, Xiaobing
author_sort Wang, Jianzheng
collection PubMed
description Desmoid tumor is a rare disease, which is histologically characterized by local invasion, monoclonality, and fibroblast proliferation; and clinically characterized by a variable and often unpredictable course. The treatment of desmoid tumor is mainly surgical resection, but the recurrence rate is high. In recent years, a variety of treatment methods, including endocrine therapy, surgery, radiotherapy, chemotherapy, non-steroidal anti-inflammatory drugs, targeted drugs, interferon and more, have been used and achieved certain curative effects. In addition, in view of the inertia characteristics of desmoid tumor, observation is also a first-line scheme recommended by multiple guidelines. In the past, the research progress of targeted therapy for desmoid tumor is relatively slow and the curative effect is limited. Thus, targeted therapy is usually used as a remedial treatment after the failure of other conventional treatment methods. However, in recent years, with the rapid progress in the basic research of targeted therapy, some new targeted drugs are increasingly used for the clinical treatment of desmoid tumor and have achieved good results. Herein, we described a patient with aggressive fibromatosis in the abdominal cavity. Following a combined treatment using anlotinib and celecoxib, the patient achieved a partial response with mild toxicity. Simultaneously, the patient’s pain symptoms completely disappeared. This case indicates that the combination of anlotinib and NSAIDs could be an effective treatment for desmoid tumor.
format Online
Article
Text
id pubmed-8792388
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-87923882022-01-28 Combination of Anlotinib and Celecoxib for the Treatment of Abdominal Desmoid Tumor: A Case Report and Literature Review Wang, Jianzheng Li, Hongle Wang, Hui Li, Qingli Bai, Xuanye Lv, Huifang Nie, Caiyun Chen, Beibei Xu, Weifeng Tu, Shuiping Chen, Xiaobing Front Oncol Oncology Desmoid tumor is a rare disease, which is histologically characterized by local invasion, monoclonality, and fibroblast proliferation; and clinically characterized by a variable and often unpredictable course. The treatment of desmoid tumor is mainly surgical resection, but the recurrence rate is high. In recent years, a variety of treatment methods, including endocrine therapy, surgery, radiotherapy, chemotherapy, non-steroidal anti-inflammatory drugs, targeted drugs, interferon and more, have been used and achieved certain curative effects. In addition, in view of the inertia characteristics of desmoid tumor, observation is also a first-line scheme recommended by multiple guidelines. In the past, the research progress of targeted therapy for desmoid tumor is relatively slow and the curative effect is limited. Thus, targeted therapy is usually used as a remedial treatment after the failure of other conventional treatment methods. However, in recent years, with the rapid progress in the basic research of targeted therapy, some new targeted drugs are increasingly used for the clinical treatment of desmoid tumor and have achieved good results. Herein, we described a patient with aggressive fibromatosis in the abdominal cavity. Following a combined treatment using anlotinib and celecoxib, the patient achieved a partial response with mild toxicity. Simultaneously, the patient’s pain symptoms completely disappeared. This case indicates that the combination of anlotinib and NSAIDs could be an effective treatment for desmoid tumor. Frontiers Media S.A. 2022-01-13 /pmc/articles/PMC8792388/ /pubmed/35096630 http://dx.doi.org/10.3389/fonc.2021.830672 Text en Copyright © 2022 Wang, Li, Wang, Li, Bai, Lv, Nie, Chen, Xu, Tu and Chen https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Wang, Jianzheng
Li, Hongle
Wang, Hui
Li, Qingli
Bai, Xuanye
Lv, Huifang
Nie, Caiyun
Chen, Beibei
Xu, Weifeng
Tu, Shuiping
Chen, Xiaobing
Combination of Anlotinib and Celecoxib for the Treatment of Abdominal Desmoid Tumor: A Case Report and Literature Review
title Combination of Anlotinib and Celecoxib for the Treatment of Abdominal Desmoid Tumor: A Case Report and Literature Review
title_full Combination of Anlotinib and Celecoxib for the Treatment of Abdominal Desmoid Tumor: A Case Report and Literature Review
title_fullStr Combination of Anlotinib and Celecoxib for the Treatment of Abdominal Desmoid Tumor: A Case Report and Literature Review
title_full_unstemmed Combination of Anlotinib and Celecoxib for the Treatment of Abdominal Desmoid Tumor: A Case Report and Literature Review
title_short Combination of Anlotinib and Celecoxib for the Treatment of Abdominal Desmoid Tumor: A Case Report and Literature Review
title_sort combination of anlotinib and celecoxib for the treatment of abdominal desmoid tumor: a case report and literature review
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792388/
https://www.ncbi.nlm.nih.gov/pubmed/35096630
http://dx.doi.org/10.3389/fonc.2021.830672
work_keys_str_mv AT wangjianzheng combinationofanlotinibandcelecoxibforthetreatmentofabdominaldesmoidtumoracasereportandliteraturereview
AT lihongle combinationofanlotinibandcelecoxibforthetreatmentofabdominaldesmoidtumoracasereportandliteraturereview
AT wanghui combinationofanlotinibandcelecoxibforthetreatmentofabdominaldesmoidtumoracasereportandliteraturereview
AT liqingli combinationofanlotinibandcelecoxibforthetreatmentofabdominaldesmoidtumoracasereportandliteraturereview
AT baixuanye combinationofanlotinibandcelecoxibforthetreatmentofabdominaldesmoidtumoracasereportandliteraturereview
AT lvhuifang combinationofanlotinibandcelecoxibforthetreatmentofabdominaldesmoidtumoracasereportandliteraturereview
AT niecaiyun combinationofanlotinibandcelecoxibforthetreatmentofabdominaldesmoidtumoracasereportandliteraturereview
AT chenbeibei combinationofanlotinibandcelecoxibforthetreatmentofabdominaldesmoidtumoracasereportandliteraturereview
AT xuweifeng combinationofanlotinibandcelecoxibforthetreatmentofabdominaldesmoidtumoracasereportandliteraturereview
AT tushuiping combinationofanlotinibandcelecoxibforthetreatmentofabdominaldesmoidtumoracasereportandliteraturereview
AT chenxiaobing combinationofanlotinibandcelecoxibforthetreatmentofabdominaldesmoidtumoracasereportandliteraturereview